Clinical Trial Update: Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating aspirin versus rivaroxaban for thromboprophylaxis in patients with multiple myeloma to prevent venous thromboembolism; currently not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Venous Thromboembolism

Drugs mentioned

• Aspirin (Aspirin)
• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Multiple Myeloma, Venous Thromboembolism | Phase 3 | Status: NOT_YET_RECRUITING